Pfizer Inc., the world #39;s biggest drugmaker, may benefit from Merck  amp; Co. #39;s withdrawal of Vioxx because Pfizer #39;s competing pain medicine Celebrex hasn #39;t been linked to increased risk of heart attacks and strokes.